Does IRBESARTAN Cause Lung neoplasm malignant? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Lung neoplasm malignant have been filed in association with IRBESARTAN (Irbesartan). This represents 0.5% of all adverse event reports for IRBESARTAN.
49
Reports of Lung neoplasm malignant with IRBESARTAN
0.5%
of all IRBESARTAN reports
35
Deaths
35
Hospitalizations
How Dangerous Is Lung neoplasm malignant From IRBESARTAN?
Of the 49 reports, 35 (71.4%) resulted in death, 35 (71.4%) required hospitalization, and 35 (71.4%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which IRBESARTAN Alternatives Have Lower Lung neoplasm malignant Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE